Skip to content
Personal information

FDA warns peanut firm about insanitary conditions, labeling

A peanut production facility in Virginia is on notice from the Food and Drug Administration for serious violations of food safety regulations regarding sanitary conditions during production, storage and transportation, and product labeling.

Officials from the FDA’s Baltimore District Office inspected the Petersburg, VA, location of Coleman Peanut Co. from Nov. 29 through Dec. 5 in 2016. They determined the company’s peanut products were prepared, packed or held under insanitary conditions whereby they may have become contaminated with filth, and may have been rendered injurious to health, according to an Aug. 2 warning letter recently made public by the FDA.

“During the inspection, FDA found that your facility had serious violations of the Current Good Manufacturing Practice (CGMP) in Manufacturing, Packing, or Holding Human Food regulation.”

FDA investigators reviewed several product labels and discovered serious labeling violations. The FDA also reviewed the company website in May 2017, where they take online orders for their peanut products at www.epeanuts.com.

“Based on our review of your product labels and your website, we have concluded that your product labeling is in violation of the food labeling regulations, Title 21, Code of Federal Regulations, which causes your products to be misbranded,” according to the warning letter.

The report cited several violations classified as significant:

The warning letter cited several significant violations in the relation to misbranded food:

In addition to the missing labeling information required by the FDA, the company also failed to use correct terms regarding several nutrient content claims. Specifically, the company used the claim, “outstanding source of protein,” but the FDA has not defined the term “outstanding source of protein” for acceptable use on food labels.

“The terms ‘high,’ ‘rich in,’ or ‘excellent source of’ may be used to characterize the level of a nutrient on the label and in the labeling of foods provided that the food contains 20 percent or more of the Daily Reference Value (DRV) per reference amount customarily consumed (RACC),” according to the warning letter.

Additionally, “the terms “good source,” “contains,” or “provides” may be used on the label provided that the food contains 10 to 19 percent of the Reference Daily Intake (RDI) or Daily Reference Value.”

These violations were a handful of the examples that rendered the firm’s peanut products to be in violation of the Federal Food, Drug, and Cosmetic Act.

The FDA allows companies 15 working days to respond to warning letters. If companies fail to properly correct violations, legal action can result in seizure of products and injunctions stopping operations. FDA has not yet posted a closeout letter on the case.

(To sign up for a free subscription to Food Safety News, click here.)

News Desk

News Desk

The News Desk team at Food Safety News covers breaking developments, regulatory updates, recalls, and key topics shaping food safety today. These articles are produced collaboratively by our editorial staff.

All articles

More in Enforcement

See all

More from News Desk

See all

Sponsored Content

Your Support Protects Public Health

Food Safety News is nonprofit and reader-funded. Your gift ensures critical coverage of outbreaks, recalls, and regulations remains free for everyone.